Principaux concurrents
Rendement du dividende (Y) Rendement du dividende (Y+1) PER (Y) Price to Book (Y) VE / CA (Y) VE / EBITDA (Y) VE / EBIT (Y) Capi.($)
- - - - - - - 552 M
0,6%0,68%17.15x1.95x3.68x9.49x10.99x 66,25 Md
0,6%0,62%26.07x3.94x5.39x15.85x19.65x 52,86 Md
-.--%-.--%33.98x6.82x11.48x21.98x25.6x 43,01 Md
3,45%3,55%-44.33x2.45x3.15x9.3x10.85x 39,52 Md
-.--%-.--%24.04x1.57x3.43x11.65x13.51x 29,19 Md
-.--%-.--%55.87x3.3x3.21x26.87x27.24x 23,13 Md
-.--%-.--%-6.71x4.07x9.37x-5.77x-5.4x 23,04 Md
-.--%0,05%66.64x5.99x6.57x45.21x51x 20,48 Md
-.--%-.--%24.35x3.57x5.21x13.64x18.86x 16,6 Md
-.--%-.--%-37.32x-6.59x17.71x-48.48x-56.03x 16,2 Md
-.--%-.--%-116.24x12691.74x12.48x-89.37x-124.56x 12,33 Md
-.--%-.--%17.31x - 3.56x13.78x16.09x 11,29 Md
-.--%-.--%45.1x - - - - 9,93 Md
0,19%0,2%49.03x19.99x29.56x41.81x43.12x 9,72 Md
2,66%3,05%12.85x1.15x1.86x7.49x10.13x 6,74 Md
0,35%0,41%29.13x - 7.85x20.82x24.86x 5,95 Md
1,64%1,82%13.95x1.26x2.39x6.25x7.55x 5,51 Md
Moyenne 0,56% 0,61% 12,41x 910,09x 7,93x 6,28x 5,84x 21,8 Md
Moyenne pondérée par Capi. 0,61% 0,65% 13,40x 432,60x 6,81x 9,54x 10,39x
Biopharmacies